Date published: 2025-10-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

C230099D08Rik Inhibitors

C230099D08Rik stands as a focal point in diverse scientific investigations, emerging as a pivotal player orchestrating crucial cellular processes by mediating specific signaling pathways. Functionally, C230099D08Rik is implicated in the intricate regulation of intracellular events, suggesting its potential contribution to fundamental processes such as cellular growth, differentiation, or survival. Its versatility becomes evident as its precise role adapts to different cellular contexts, underscoring its significance in modulating a spectrum of molecular processes. In the realm of molecular mechanisms, inhibiting C230099D08Rik often involves targeting key nodes within interconnected signaling cascades. Chemical inhibitors, such as those highlighted earlier, exert their influence on specific components within these pathways. This sets off a cascade of events that intricately impact the function of C230099D08Rik. The specific interactions orchestrated by these inhibitors may lead to altered expression levels or modified activity of C230099D08Rik, resulting in a spectrum of diverse cellular outcomes.

The profound impact of these inhibitors lies in their ability to unravel the complexities of signaling pathways that converge upon C230099D08Rik. By deciphering these intricate networks, researchers gain insights into the nuanced interplay between C230099D08Rik and its molecular counterparts. This knowledge becomes paramount in comprehending the multifaceted roles played by C230099D08Rik in different cellular scenarios. Understanding the delicate balance of signaling pathways and the precise molecular mechanisms governing C230099D08Rik's inhibition is essential for advancing our comprehension of cellular regulation. The intricate web of interactions and cross-talk between signaling cascades sheds light on the adaptability of C230099D08Rik in responding to diverse cellular cues. Researchers strive to uncover the specific events triggered by these inhibitors, offering a roadmap to comprehend the intricacies of C230099D08Rik's functional modulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

AZD5363

1143532-39-1sc-503190
5 mg
$309.00
(0)

AKT inhibitor disrupting the PI3K/Akt/mTOR pathway, potentially modulating cellular processes linked to C230099D08Rik.

GDC-0941

957054-30-7sc-364498
sc-364498A
5 mg
10 mg
$184.00
$195.00
2
(1)

PI3K inhibitor targeting the PI3K/Akt/mTOR pathway, influencing downstream events that may indirectly affect C230099D08Rik.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAPK inhibitor affecting stress response pathways, potentially impacting cellular processes connected to C230099D08Rik.

Selumetinib

606143-52-6sc-364613
sc-364613A
sc-364613B
sc-364613C
sc-364613D
5 mg
10 mg
100 mg
500 mg
1 g
$28.00
$80.00
$412.00
$1860.00
$2962.00
5
(1)

MEK inhibitor targeting the MAPK/ERK pathway, potentially influencing downstream effectors related to C230099D08Rik.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A non-specific PI3K inhibitor disrupting PI3K-dependent signaling cascades, which may indirectly impact pathways associated with C230099D08Rik.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor influencing the JNK signaling pathway, potentially exerting indirect effects on cellular processes related to C230099D08Rik.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor affecting the PI3K/Akt/mTOR pathway, with potential downstream consequences on cellular events associated with C230099D08Rik.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$246.00
$490.00
$536.00
16
(1)

JAK1/2 inhibitor disrupting the JAK/STAT pathway, potentially affecting cellular processes connected to C230099D08Rik.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MEK1 inhibitor impacting the MAPK/ERK pathway, potentially altering processes associated with C230099D08Rik.

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$35.00
$115.00
$515.00
26
(1)

Inhibitor of the Wnt pathway, acting on tankyrase and potentially modulating cellular processes related to C230099D08Rik.